all reports of adverse reactions with pyrimethamine-sulphadoxine ( fansidar ) , pyrimethamine-dapsone ( maloprim ) , and amodiaquine spontaneously reported through the uk national post-marketing system were reviewed .
C0700599
pyrimethamine-sulphadoxine
C0060061
fansidar